Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in relapsing non-severe granulomatosis with polyangiitis
NCT02108860Phase 3Completed
- Sponsor
- University of South Florida
- Start
- Apr 2015
- Primary completion
- Jul 2023
- Modality
- Fc-Fusion Proteins
- Countries
- 5
01
Overview
A Phase 3 trial of abatacept in granulomatosis with polyangiitis (GPA), sponsored by University of South Florida. Started Apr 2015; status: completed.
02
Drugs
abatacept
03
Conditions
granulomatosis with polyangiitis (GPA)
Beyond the preview
Go deeper on NCT02108860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02108860.